drugset / Trial / NCT01956149
Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer
Phase 2
Completed
65 enrolled
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
NaSingle-groupOpen-labelTreatment
Summary
Single-arm study to determine disease control rate in second- (or later) line treatment with cabazitaxel after the failure of palliative primary treatment.
Timeline
- Start
- 2013-09
- Primary completion
- 2017-12
- Completion
- 2018-04-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cabazitaxel | Other / unclassified | 20 mg/m2 | Intravenous |